Kulkarni Samarth
Reporting owner on Forms 3, 4 and 5, CIK 1682019.
Kulkarni Samarth reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-15.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| CRSP · CRISPR Therapeutics AGCIK 1674416 | director, officer (Chief Executive Officer) | 1 | 2026-10-15 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| CRSP · CRISPR Therapeutics AGCommon Shares | 2026-10-14 | S sold | -4,098 | $49.26 | 259,736 | Form 4 |
| CRSP · CRISPR Therapeutics AGCommon Shares | 2026-10-13 | M exercised | +8,333 | 263,834 | Form 4 | |
| CRSP · CRISPR Therapeutics AGRestricted Stock Units, derivative | 2026-10-13 | M exercised | -8,333 | 0 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001193125-26-423056 | CRISPR Therapeutics AG | 2026-10-15 |